HEADER TRANSFERASE 12-SEP-99 1D0K TITLE THE ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 IN COMPLEX WITH TWO TITLE 2 MURODIPEPTIDES (GLCNAC-MURNAC-L-ALA-D-GLU) CAVEAT 1D0K AMU C 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 35KD SOLUBLE LYTIC TRANSGLYCOSYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SLT35; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALPHA-HELICAL PROTEIN WITH A FIVE-STRANDED ANTIPARALLEL BETA-SHEET, KEYWDS 2 GLYCOSYLTRANSFERASE, EF-HAND, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.J.VAN ASSELT,K.H.KALK,B.W.DIJKSTRA REVDAT 7 07-FEB-24 1D0K 1 REMARK REVDAT 6 03-NOV-21 1D0K 1 SEQADV HETSYN REVDAT 5 29-JUL-20 1D0K 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1D0K 1 VERSN REVDAT 3 15-SEP-10 1D0K 1 LINK SITE REVDAT 2 24-FEB-09 1D0K 1 VERSN REVDAT 1 06-MAR-00 1D0K 0 JRNL AUTH E.J.VAN ASSELT,K.H.KALK,B.W.DIJKSTRA JRNL TITL CRYSTALLOGRAPHIC STUDIES OF THE INTERACTIONS OF ESCHERICHIA JRNL TITL 2 COLI LYTIC TRANSGLYCOSYLASE SLT35 WITH PEPTIDOGLYCAN. JRNL REF BIOCHEMISTRY V. 39 1924 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 10684641 JRNL DOI 10.1021/BI992161P REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.843 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0001 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 25892 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2601 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.02 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1837 REMARK 3 BIN R VALUE (WORKING SET) : 0.2050 REMARK 3 BIN FREE R VALUE : 0.2190 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 213 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2488 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 103 REMARK 3 SOLVENT ATOMS : 362 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.040 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.530 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.300 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.580 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.890 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1D0K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-99. REMARK 100 THE DEPOSITION ID IS D_1000009683. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-OCT-97 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26200 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 23.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.26700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BICINE-NAOH, ISOPROPANOL, PEG20K, PH REMARK 280 7.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.18950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.47000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.91250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.47000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.18950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.91250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THREE DOMAIN STRUCTURE: ALPHA DOMAIN WITH RESIDUES 40-98, REMARK 400 170-215, BETA DOMAIN WITH RESIDUES 270-329, CORE DOMAIN REMARK 400 WITH RESIDUES 109-169, 216-269, 330-361. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 101 REMARK 465 THR A 102 REMARK 465 SER A 103 REMARK 465 VAL A 104 REMARK 465 LYS A 105 REMARK 465 PRO A 106 REMARK 465 PRO A 107 REMARK 465 SER A 108 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 40 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C ALA A 407 N DGL A 408 1.33 REMARK 500 C10 AMU C 1 N ALA A 407 1.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 163 13.16 -140.03 REMARK 500 TYR A 185 79.63 -151.66 REMARK 500 HIS A 340 73.26 -67.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE COORDINATES CONTAIN A MURODIPEPTIDE: REMARK 600 (GLCNAC-MURNAC-L-ALA-D-GLU). REMARK 600 MURODIPEPTIDE A (RESIDUES 401-404) HAS AN OCCUPANCY REMARK 600 OF 0.5 AND BINDS IN SUBSITES -2 AND -1. REMARK 600 GLYCEROL 3007 AND WATER MOLECULES 3001-3006 ALSO HAVE REMARK 600 AN OCCUPANCY OF 0.5 AND ARE LOCATED IN SUBSITES -2 REMARK 600 AND -1, RESPECTIVELY. REMARK 600 MURODIPEPTIDE B (RESIDUES 405-408) BINDS IN SUBSITES REMARK 600 +1 AND +2. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 AMU B 1 REMARK 610 AMU C 1 REMARK 610 ALA A 403 REMARK 610 ALA A 407 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 400 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 237 OD1 REMARK 620 2 SER A 239 OG 87.4 REMARK 620 3 ASP A 241 OD1 77.1 81.1 REMARK 620 4 HIS A 243 O 77.7 159.5 81.8 REMARK 620 5 ASP A 251 OD2 105.9 123.2 155.3 75.1 REMARK 620 6 ASP A 251 OD1 93.0 74.8 154.3 119.5 50.1 REMARK 620 7 HOH A 574 O 165.0 84.1 89.4 107.0 89.1 96.7 REMARK 620 N 1 2 3 4 5 6 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QUS RELATED DB: PDB REMARK 900 NATIVE SLT35 STRUCTURE AT 1.7 ANG. RESOLUTION. REMARK 900 RELATED ID: 1QUT RELATED DB: PDB REMARK 900 SLT35 IN COMPLEX WITH GLCNAC REMARK 900 RELATED ID: 1QDR RELATED DB: PDB REMARK 900 SLT35 IN COMPLEX WITH NA+ REMARK 900 RELATED ID: 1QDT RELATED DB: PDB REMARK 900 SLT35 IN COMPLEX WITH CA2+ REMARK 900 RELATED ID: 1D0K RELATED DB: PDB REMARK 900 SLT35 IN COMPLEX WITH TWO MURODIPEPTIDES (GLCNAC-MURNAC-L-ALA-D-GLU) REMARK 900 RELATED ID: 1D0L RELATED DB: PDB REMARK 900 SLT35 IN COMPLEX WITH BULGECIN A REMARK 900 RELATED ID: 1D0M RELATED DB: PDB REMARK 900 SLT35 IN COMPLEX WITH BULGECIN A AND (GLCNAC)2 DBREF 1D0K A 40 361 UNP P41052 MLTB_ECOLI 40 361 SEQADV 1D0K MET A 40 UNP P41052 LEU 40 ENGINEERED MUTATION SEQADV 1D0K VAL A 41 UNP P41052 LEU 41 ENGINEERED MUTATION SEQRES 1 A 322 MET VAL GLU PRO GLN HIS ASN VAL MET GLN MET GLY GLY SEQRES 2 A 322 ASP PHE ALA ASN ASN PRO ASN ALA GLN GLN PHE ILE ASP SEQRES 3 A 322 LYS MET VAL ASN LYS HIS GLY PHE ASP ARG GLN GLN LEU SEQRES 4 A 322 GLN GLU ILE LEU SER GLN ALA LYS ARG LEU ASP SER VAL SEQRES 5 A 322 LEU ARG LEU MET ASP ASN GLN ALA PRO THR THR SER VAL SEQRES 6 A 322 LYS PRO PRO SER GLY PRO ASN GLY ALA TRP LEU ARG TYR SEQRES 7 A 322 ARG LYS LYS PHE ILE THR PRO ASP ASN VAL GLN ASN GLY SEQRES 8 A 322 VAL VAL PHE TRP ASN GLN TYR GLU ASP ALA LEU ASN ARG SEQRES 9 A 322 ALA TRP GLN VAL TYR GLY VAL PRO PRO GLU ILE ILE VAL SEQRES 10 A 322 GLY ILE ILE GLY VAL GLU THR ARG TRP GLY ARG VAL MET SEQRES 11 A 322 GLY LYS THR ARG ILE LEU ASP ALA LEU ALA THR LEU SER SEQRES 12 A 322 PHE ASN TYR PRO ARG ARG ALA GLU TYR PHE SER GLY GLU SEQRES 13 A 322 LEU GLU THR PHE LEU LEU MET ALA ARG ASP GLU GLN ASP SEQRES 14 A 322 ASP PRO LEU ASN LEU LYS GLY SER PHE ALA GLY ALA MET SEQRES 15 A 322 GLY TYR GLY GLN PHE MET PRO SER SER TYR LYS GLN TYR SEQRES 16 A 322 ALA VAL ASP PHE SER GLY ASP GLY HIS ILE ASN LEU TRP SEQRES 17 A 322 ASP PRO VAL ASP ALA ILE GLY SER VAL ALA ASN TYR PHE SEQRES 18 A 322 LYS ALA HIS GLY TRP VAL LYS GLY ASP GLN VAL ALA VAL SEQRES 19 A 322 MET ALA ASN GLY GLN ALA PRO GLY LEU PRO ASN GLY PHE SEQRES 20 A 322 LYS THR LYS TYR SER ILE SER GLN LEU ALA ALA ALA GLY SEQRES 21 A 322 LEU THR PRO GLN GLN PRO LEU GLY ASN HIS GLN GLN ALA SEQRES 22 A 322 SER LEU LEU ARG LEU ASP VAL GLY THR GLY TYR GLN TYR SEQRES 23 A 322 TRP TYR GLY LEU PRO ASN PHE TYR THR ILE THR ARG TYR SEQRES 24 A 322 ASN HIS SER THR HIS TYR ALA MET ALA VAL TRP GLN LEU SEQRES 25 A 322 GLY GLN ALA VAL ALA LEU ALA ARG VAL GLN HET AMU B 1 19 HET NAG B 2 14 HET AMU C 1 19 HET NAG C 2 14 HET CA A 400 1 HET ALA A 403 5 HET DGL A 404 10 HET ALA A 407 5 HET DGL A 408 10 HET GOL A3007 6 HETNAM AMU N-ACETYL-BETA-MURAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM ALA ALANINE HETNAM DGL D-GLUTAMIC ACID HETNAM GOL GLYCEROL HETSYN AMU N-ACETYL-MURAMIC ACID; BETA-N-ACETYLMURAMIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 AMU 2(C11 H19 N O8) FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 4 CA CA 2+ FORMUL 5 ALA 2(C3 H7 N O2) FORMUL 6 DGL 2(C5 H9 N O4) FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *362(H2 O) HELIX 1 1 ASN A 57 GLY A 72 1 16 HELIX 2 2 ASP A 74 SER A 83 1 10 HELIX 3 3 LEU A 88 GLN A 98 1 11 HELIX 4 4 GLY A 112 ILE A 122 1 11 HELIX 5 5 THR A 123 TYR A 137 1 15 HELIX 6 6 TYR A 137 GLY A 149 1 13 HELIX 7 7 PRO A 151 ARG A 164 1 14 HELIX 8 8 ILE A 174 ASN A 184 1 11 HELIX 9 9 TYR A 185 ARG A 187 5 3 HELIX 10 10 ARG A 188 GLU A 206 1 19 HELIX 11 11 ASP A 209 ASN A 212 5 4 HELIX 12 12 MET A 227 ALA A 235 1 9 HELIX 13 13 ASP A 248 HIS A 263 1 16 HELIX 14 14 ILE A 292 ALA A 298 1 7 HELIX 15 15 LEU A 329 ARG A 337 1 9 HELIX 16 16 SER A 341 GLN A 361 1 21 SHEET 1 A 2 THR A 172 ARG A 173 0 SHEET 2 A 2 LYS A 214 GLY A 215 -1 N GLY A 215 O THR A 172 SHEET 1 B 5 GLY A 285 SER A 291 0 SHEET 2 B 5 GLN A 311 ASP A 318 -1 N ALA A 312 O TYR A 290 SHEET 3 B 5 TYR A 323 GLY A 328 -1 O GLN A 324 N LEU A 317 SHEET 4 B 5 ALA A 272 ASN A 276 -1 O VAL A 273 N TYR A 327 SHEET 5 B 5 THR A 301 PRO A 302 -1 O THR A 301 N ASN A 276 LINK O4 AMU B 1 C1 ANAG B 2 1555 1555 1.44 LINK O4 AMU C 1 C1 NAG C 2 1555 1555 1.43 LINK OD1 ASP A 237 CA CA A 400 1555 1555 2.41 LINK OG SER A 239 CA CA A 400 1555 1555 2.42 LINK OD1 ASP A 241 CA CA A 400 1555 1555 2.45 LINK O HIS A 243 CA CA A 400 1555 1555 2.37 LINK OD2 ASP A 251 CA CA A 400 1555 1555 2.50 LINK OD1 ASP A 251 CA CA A 400 1555 1555 2.66 LINK CA CA A 400 O HOH A 574 1555 1555 2.43 CISPEP 1 GLY A 109 PRO A 110 0 0.20 CRYST1 58.379 67.825 98.940 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017129 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014744 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010107 0.00000